Description of Collaborative Activity: |
More than 100 participants attended the “Assay Guidance Workshop for High-Throughput Screening and Lead Discovery” on April 5–6, 2016, in College Park, Maryland. Hosted by NCATS and the Food and Drug Administration (FDA), the workshop was designed to provide participants with a broad and practical perspective on how to develop and implement robust assays for early-stage drug discovery projects. Participants included researchers from thirteen NIH centers, FDA, National Institute of Standards and Technology, the Department of Defense, industry and academia. Workshop leaders with more than 20 years of drug discovery experience covered a broad range of critical concepts underlying robust assay development and screening strategies. There were also open discussions for participants to share experiences and seek practical advice about individual research interests. |
NIH Participating Institutes/Centers/Office of the Director: |
CC, NCATS, NCI, NEI, NHGRI, NHLBI, NIAID, NIAMS, NICHD, NIDA, NIDCR, NIDDK, NINDS |